DiNuzzo Private Wealth
INDV icon

DiNuzzo Private Wealth’s Indivior Pharmaceuticals INDV Stock Holding History

DiNuzzo Private Wealth’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$287 Hold
8
– – ﹤0.01% 1215
2026
Q2 		$329 Buy
+8
New +$290 ﹤0.01% 1194

Other funds holding INDV

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

DiNuzzo Private Wealth's INDV Position: Q3 2026 in Review

DiNuzzo Private Wealth held its Indivior Pharmaceuticals (INDV) position steady in Q3 2026 at 8 shares worth $287. The position accounts for ﹤0.01% of the portfolio, ranked #1215.

DiNuzzo Private Wealth first reported a position in INDV in Q2 2026 and has held it in 2 quarters since. The position peaked at $329 in Q2 2026. 59 funds tracked by Wall St. Rank hold INDV as of Q3 2026.

  • DiNuzzo Private Wealth held 8 shares of Indivior Pharmaceuticals worth $287 as of Q3 2026.
  • DiNuzzo Private Wealth left its Indivior Pharmaceuticals share count unchanged in Q3 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #1215 holding.
  • DiNuzzo Private Wealth first reported a position in Indivior Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • DiNuzzo Private Wealth's Indivior Pharmaceuticals position peaked at $329 in Q2 2026.
  • 59 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.